Cardinal Health Enters Material Definitive Agreement

Ticker: CAH · Form: 8-K · Filed: Oct 10, 2025 · CIK: 721371

Cardinal Health INC 8-K Filing Summary
FieldDetail
CompanyCardinal Health INC (CAH)
Form Type8-K
Filed DateOct 10, 2025
Risk Levelmedium
Pages2
Reading Time3 min
Key Dollar Amounts$1.0 billion
Sentimentneutral

Sentiment: neutral

Topics: material-agreement, filing

TL;DR

Cardinal Health just signed a big deal, filing an 8-K on 10/7/25.

AI Summary

On October 7, 2025, Cardinal Health, Inc. entered into a material definitive agreement. The filing also includes financial statements and exhibits related to this agreement. The company, incorporated in Ohio with its principal executive offices in Dublin, Ohio, is a wholesale distributor of drugs and sundries.

Why It Matters

This filing indicates a significant new contract or partnership for Cardinal Health, which could impact its future revenue and operational landscape.

Risk Assessment

Risk Level: medium — Entering into a material definitive agreement can introduce new risks and opportunities that may affect the company's financial performance and market position.

Key Players & Entities

FAQ

What is the nature of the material definitive agreement entered into by Cardinal Health, Inc.?

The filing does not specify the exact nature of the material definitive agreement, only that one was entered into on October 7, 2025.

When was this Form 8-K filed with the SEC?

This Form 8-K was filed on October 10, 2025.

In which state is Cardinal Health, Inc. incorporated?

Cardinal Health, Inc. is incorporated in Ohio.

What is Cardinal Health's primary business as indicated by its SIC code?

Cardinal Health's SIC code (5122) indicates its business is wholesale distribution of drugs, proprietaries, and druggists' sundries.

What is the telephone number listed for Cardinal Health, Inc.?

The telephone number listed for Cardinal Health, Inc. is (614) 757-5000.

Filing Stats: 708 words · 3 min read · ~2 pages · Grade level 12.3 · Accepted 2025-10-10 06:33:04

Key Financial Figures

Filing Documents

01 Entry Into A Material Definitive Agreement

Item 1.01 Entry Into A Material Definitive Agreement On October 7, 2025, Cardinal Health, Inc. (the "Company"), Bank of America, N.A., as Administrative Agent and each lender from time to time party thereto entered into a 364-Day Credit Agreement (the "Credit Agreement"). This Company entered into the Credit Agreement following the expiration of the 364-Day Credit Agreement into which it entered in October, 2024. The Credit Agreement, among other things, allows the Company access to $1.0 billion of revolving credit through October 6, 2026 (the "Termination Date"). The Company is permitted, subject to certain conditions specified in the Credit Agreement, to elect to have the principal of any loans outstanding on the Termination Date converted into non-revolving term loans, which shall be repaid in full on the date that is one year after the Termination Date. The Credit Agreement contains customary representations and affirmative and negative covenants. The financial covenant in the Credit Agreement requires the Company to maintain, as of the last day of any fiscal quarter, a Consolidated Net Leverage Ratio, as such term is defined in the Credit Agreement and subject to certain conditions contained therein, of no greater than 3.75 to 1.00. The Credit Agreement also contains customary events of default (including non-payment of principal or interest and breaches of covenants). This revolving credit facility may be used for general corporate purposes and backs the Company's commercial paper program. The descriptions of the provisions of the Credit Agreement are summary in nature and are qualified in their entirety by reference to the full and complete terms of the Credit Agreement, which is filed herewith as Exhibit 10.1. Certain of the financial institutions party to the Credit Agreement and the Issuing and Paying Agency Agreement or their respective affiliates, and the dealers under the Company's commercial paper program, have performed and may in the future

01: Financial Statements and Exhibits

Item 9.01: Financial Statements and Exhibits (d) Exhibits Exhibit Number Exhibit Description 10.1 364-Day Credit Agreement, dated October 7, 2025 104 Cover Page Interactive Data File (embedded within the Inline XBRL document) 2

Signatures

Signatures Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized. Cardinal Health, Inc. (Registrant) Date: October 10, 2025 By: /s/ AARON E. ALT Aaron E. Alt Chief Financial Officer 3

View Full Filing

View this 8-K filing on SEC EDGAR

View on Read The Filing